Aurobindo To Buy Controlling Stakes In Celon, Silicon Life Sciences
This article was originally published in PharmAsia News
Executive Summary
In an all-India deal, Aurobindo Pharma said one of its subsidiaries, which it did not name, would be making acquisitions and joint ventures, including a $2.6 million stake in a Celon Laboratories manufacturing facility under construction.